A new ligand extends the half-life of peptide drugs from minutes to days

EPFL scientists have developed a ligand molecule that connects peptide drugs to blood-serum albumin and keeps them from being cleared out by the kidneys too soon. The ligand is easy to synthesize and can extend the half-life of therapeutic peptides from minutes to several days. …read more

Source: EurekAlert

(Visited 7 times, 1 visits today)

Popular Posts